Jinghua Pharmaceutical Group Co Ltd
Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 002349-SZ would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2010) — listing | $28,980 1.2× | $42,829 1.2× |
| Year 6 (2015) | $16,020 1.0× | $23,631 1.0× |
| Year 11 (2020) | $9,342 1.0× | $13,824 1.0× |
| Year 16 (2025) | $1,948 1.0× | $2,906 1.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 002349
For illustration only — not investment advice. Past performance is not indicative of future results.